Veeral Desai, Chief Strategy & Development Officer at agilon health, inc. (AGL), sold 60,000 shares at $26.09 ($1.6M) on 2023-03-16, disclosed to the SEC on 2023-03-17.
Open-market sale of $1.6M AGL by Chief Strategy & Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AGL | SELL | 2023-03-27 | $4.1M | — | Filing → |
| AGL | SELL | 2022-07-25 | $2.2M | — | Filing → |
| AGL | SELL | 2022-07-11 | $8.0M | — | Filing → |